Summary
Generates structured meeting briefing documents, question strategies, and precedent-based response preparation for FDA Type A, B, and C meetings.
Detailed Description
The Pre-Submission Meeting Prep Pack transforms FDA meeting preparation from an ad hoc process into an evidence-driven practice. It compiles FDA meeting guidance, historical meeting minutes and outcomes, and regulatory precedents to help sponsors prepare comprehensive briefing documents and anticipate FDA feedback.
The pack analyzes your meeting type (Type A, B, or C), development stage, and key questions to generate a structured briefing document outline aligned with FDA expectations. It identifies precedent meeting outcomes for similar development programs and predicts likely FDA positions on your key questions based on historical patterns.
Deliverables include a meeting briefing document template with precedent-informed content, a question-by-question FDA response prediction analysis, and a contingency planning framework for potential FDA pushback scenarios.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| FDA Meeting Guidance | REGULATORY | FDA guidance on formal meetings including Type A, B, C meeting procedures and content expectations | Monthly |
| Meeting Outcome Precedents | CURATED | Curated database of FDA meeting outcomes, minutes, and sponsor questions with FDA responses | Quarterly |
| CDER Review Standards | REGULATORY | CDER review standards and manual of policies and procedures relevant to meeting preparation | Quarterly |
Regulatory Mapping
Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
PDUFA Reauthorization Performance Goals and Procedures
Manual of Policies and Procedures: Formal Meetings
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
Meeting Briefing Document Template
DOCXStructured briefing document template with precedent-informed content for FDA meeting
FDA Response Prediction Analysis
PDFQuestion-by-question analysis of likely FDA positions based on historical meeting outcomes
Contingency Planning Framework
PDFDecision trees and contingency strategies for potential FDA pushback scenarios
Deliverables included
- Meeting briefing document template
- Question-by-question FDA response predictions
- Contingency planning for FDA pushback scenarios
- Meeting logistics and timeline checklist
- Post-meeting follow-up action framework
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Cross-Therapeutic | Regulatory Strategy | N/A — regulatory focus | Primary |
| Oncology | Accelerated Approval Programs | ORRDORctDNA response | Secondary |
Related Packs in Regulatory Strategy
FDA IND Strategy Pack
File your IND right the first time
FDA/EMA Alignment Pack
Harmonize your global regulatory strategy
Breakthrough/Fast Track Evidence Pack
Maximize your chances for expedited designation
Global Regulatory Intelligence Pack
Track regulatory shifts across 40+ markets in real time
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.